Angiocrine Bioscience Announces Oral Presentation of Intravenous AB-205 Data during the Annual Transplantation & Cellular Therapy Meetings of ASCT and CIBMTR
- Friday, February 5, 2021, 7:00
- Finance
- Add a comment
SAN DIEGO, Feb. 5, 2021 /PRNewswire/ — Angiocrine Bioscience Inc., a clinical-stage biopharmaceutical company today announced that the American Society for Transplantation and Cellular Therapy (ASTCT) and the Center for International Blood & Marrow Transplant Research (CIBMTR) has…
About the Author
adminasapcorp has written 41552 stories on this site.